43 related articles for article (PubMed ID: 6861192)
1. Rat serum factors inhibiting the G1-S transition in hepatocytes. II. Properties of the low molecular weight factor.
Le Rumeur E; Winchenne JJ; Boffa GA; Nadal C
Cell Tissue Kinet; 1983 Jul; 16(4):333-42. PubMed ID: 6861192
[TBL] [Abstract][Full Text] [Related]
2. Rat serum factors inhibiting the G1-S transition in hepatocytes. I. Production of a low molecular weight inhibitor by proteases or liver fractions.
Nadal C; Le Rumeur E; Boffa GA
Cell Tissue Kinet; 1981 Nov; 14(6):601-9. PubMed ID: 7296626
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of human alpha 2-macroglobulin and a peptide released by trypsin, on the G1-S transition of hepatocytes in vivo].
Boffa GA; Lambin P; Rius E; Nadal C
C R Acad Sci III; 1985; 300(2):31-6. PubMed ID: 2578862
[TBL] [Abstract][Full Text] [Related]
4. [Demonstration in human plasma of 2 factors inhibiting hepatocyte multiplication by blocking the cell cycle at the level of G1-S transition].
Rius E; Nadal C; Boffa GA
C R Acad Sci III; 1984; 299(5):119-22. PubMed ID: 6432231
[TBL] [Abstract][Full Text] [Related]
5. [Detection and purification of a liver microsomal enzyme inducing the release of a glycopeptide inhibitor of hepatocyte proliferation from human alpha 2 macroglobulin].
Leborgne C; Nadal C; Winchenne JJ; Boffa GA
C R Seances Soc Biol Fil; 1987; 181(2):137-44. PubMed ID: 2441826
[TBL] [Abstract][Full Text] [Related]
6. Purification and partial characterization of a hepatocyte antiproliferative glycopeptide.
Auger G; Blanot D; van Heijenoort J; Nadal C; Gournay MF; Winchenne JJ; Boffa GA; Lambin P; Maes P; Tartar A
J Cell Biochem; 1989 Aug; 40(4):439-51. PubMed ID: 2476452
[TBL] [Abstract][Full Text] [Related]
7. Biochemical properties of the high-molecular-weight glycopeptides released from the cell surface of human teratocarcinoma cells.
Muramatsu H; Muramatsu T; Avner P
Cancer Res; 1982 May; 42(5):1749-52. PubMed ID: 6802482
[TBL] [Abstract][Full Text] [Related]
8. [Release from human alpha 2-macroglobulin of a peptide inhibitor of G1-S transition of hepatocytes in vivo. Role of trypsin, thrombin and various chemical agents].
Lambin P; Nadal C; Winchenne JJ; Boffa GA
C R Acad Sci III; 1987; 304(19):477-80. PubMed ID: 2438019
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatocyte proliferation in vivo by a glycopeptide from rat serum.
Nadal C
Cell Tissue Kinet; 1987 May; 20(3):331-41. PubMed ID: 3690625
[TBL] [Abstract][Full Text] [Related]
10. Partial purification of rat and human serum factors inhibiting the G1-S transition in rat hepatocytes.
Auger G; Blanot D; van Heijenoort J; Nadal C; Gournay MF
Eur J Biochem; 1983 Jun; 133(2):363-9. PubMed ID: 6852047
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
[TBL] [Abstract][Full Text] [Related]
12. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of the cyclin-dependent kinase inhibitor P27 in primary hepatocytes in early-mid G1 and G1/S transitions.
McIntyre M; Desdouets C; Sénamaud-Beaufort C; Laurent-Winter C; Lamas E; Bréchot C
Oncogene; 1999 Aug; 18(32):4577-85. PubMed ID: 10467402
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
15. Changes in fucosyl-glycopeptides during early post-implantation embryogenesis in the mouse.
Muramatsu T; Condamine H; Gachelin G; Jacob F
J Embryol Exp Morphol; 1980 Jun; 57():25-36. PubMed ID: 7430933
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory and anti-inhibitory factors of rat serum active on the G1-S transition of hepatocyte cell cycle.
Nadal C; Boffa GA
Cell Tissue Kinet; 1975 Jul; 8(4):297-305. PubMed ID: 50134
[TBL] [Abstract][Full Text] [Related]
17. Glycerophosphorylethanolamine (GPEA) identified as an hepatocyte growth stimulator in liver extracts.
Nelson C; Moffat B; Jacobsen N; Henzel WJ; Stults JT; King KL; McMurtrey A; Vandlen R; Spencer SA
Exp Cell Res; 1996 Nov; 229(1):20-6. PubMed ID: 8940245
[TBL] [Abstract][Full Text] [Related]
18. Processing/activation of CPP32-like proteases is involved in transforming growth factor beta1-induced apoptosis in rat hepatocytes.
Inayat-Hussain SH; Couet C; Cohen GM; Cain K
Hepatology; 1997 Jun; 25(6):1516-26. PubMed ID: 9185777
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
20. Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
Harada N; Okajima K; Uchiba M
Crit Care Med; 2006 Jul; 34(7):1883-91. PubMed ID: 16641616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
